Skip to main content

Stem Cells Signal Mouse's Own Cells To Mend The Fracture

Image
By
Treatment with bone marrow-derived stem cells could prove to be an effective strategy for slow healing bone fractures in diabetics, a pre-clinical study suggested.

When nondiabetic human bone marrow-derived mesenchymal stem cells (hMSCs) were administered directly to femur fractures in a murine model of diabetes, the bones healed more efficiently than nontreated bone, reported Cynthia Coleman, PhD, of the National University of Ireland in Galway, and colleagues.

he stem-cell treated bones were also significantly stronger than nontreated bone, they stated in a report at the 2015 European Congress of Endocrinology (ECE) meeting.

Both the metabolic and endocrine impact of diabetes can adversely affect bone quality and may increase fracture risk. Lower bone mass and increased fracture risk have long been recognized as a complication of type 1 diabetes, and fracture is also increasingly recognized as a concern for patients with type 2 diabetes, despite their often higher, obesity-related bone density.

Fractures in patients with both type 1 and type 2 diabetes are also slower to heal, and diabetic patients have an increased risk for suboptimal healing.
In an ECE abstract, Coleman and colleagues wrote that, "given the known deficiencies in diabetic progenitor cell number and differentiation capacity, it is reasonable to hypothesize the etiology of diabetic fracture malunion is dysregulated progenitor function."

To test this hypothesis, they performed a 56-day, dose escalation study in which they administered hMSCs locally to femoral fractures in the diabetic mouse model.

The mice were evaluated weekly, which included monitoring of their weight, blood glucose levels, and terminal levels of circulating HbA1c. Both animals treated with the hMSCs and control animals treated with saline had similar body weight, blood glucose levels, and HbA1c levels over the course of the study.

Micro CT analysis revealed an increase in bone volume, along with a statistically significant decrease in the ratio of bone surface area to bone volume in animals treated with hMSCs, compared with the saline-treated animals.

Additional analysis, using the four-point bending strategy, showed a statistically significant increase in ultimate stress and e-modulus of the repairing bone, the researchers noted.

"Although the local administration of hMSCs did not alter the organismal diabetic condition, treatment of the diabetic fracture with hMSCs resulted in enhanced mechanical integrity of de novo reparative bone," they wrote.

The researchers were also able to determine that the stem cells did not permanently integrate into the mouse host tissue. Instead, the cells produced signals that prompted the mouse's own cells to heal the fracture.

"This basic science study allows us to better understand the role of stem cells in fracture repair and potential use in treating diabetic patients," Coleman noted in a press statement. "Stem cells represent an exciting potential for improving the treatment and lessening the pain and discomfort of diabetic people who break bones."

Source : http://goo.gl/zaZF27

Comments

Post a Comment

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

By
The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...
Post a Comment
Read more

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

By
 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...
Post a Comment
Read more

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

By
Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...
Post a Comment
Read more